ABLi Therapeutics (“ABLi”), a biotechnology company developing therapeutics to address diseases that arise from activation of Abelson Tyrosine Kinases (c-Abl kinases), announced today that Milton H.

GAINESVILLE, FL AND NASHVILLE, TN / ACCESS Newswire / March 6, 2026 / American Rebel Beverages, a subsidiary of American ...